Sign up to save your podcasts
Or
Share A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
132 Listeners
Global News Podcast
7,683 Listeners
Neurology® Podcast
285 Listeners
NEJM This Week
322 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
496 Listeners
JAMA Neurology Author Interviews
14 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
363 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
77 Listeners